12 days ago | By Healio
A biopharmaceutical company announced the first participants have been dosed in its phase 1 clinical trial of PH10, an investigational pherine nasal spray to treat major depressive disorder.
According to a release from Vistagen, the objective of its planned single-center, randomized, double-blinded, placebo-controlled phase 1 study is to investigate the safety and tolerability of PH10 in 12 healthy adult subjects.
The clinical trial is also intended to confirm the favorable safety profile of PH10 previously established in three prior clinical studies conducted in Mexico, including a published
Read more ...
12 days ago | By MedPageToday
An investigational N,N-dimethyltryptamine treatment - commonly known as the hallucinogen DMT - achieved the primary endpoint in a phase IIa trial for major depressive disorder , developer Small Pharma announced.
Paired...
Read more ...
12 days ago | By Daily Mail
Up to six in ten who received a single dose of DMT intravenously before therapy were declared depression-free three months later, in a clinical trial by Canada-based Small Pharma.
Read more ...
Established 2013. Read more ...
Ziath has launched its next generation DataPaq™ Handheld 2 tube reader - designed to be held and operated in one hand, leaving the other free for tube handling. Read more ...
Melbourne's Turkish community is rallying around those affected by the earthquake in their homeland. Read more ...
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients. However, treatment initiation can... Read more ...
See-through' toilets at popular Auckland bar HQ are covered up after complaints Read more ...
On November 25, more people used Brisbane's toll roads than ever before, but public transport's post-pandemic journey is not going so smoothly. Read more ...
Risk model-based lung cancer screening strategies, which select individuals based on personal risk, are more cost effective than current recommendations based solely on age and... Read more ...
In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the... Read more ...
Separatist fighters in Indonesia's Papua region claim to have taken a New Zealand pilot hostage after setting a small plane alight when it landed. Read more ...
Funding will enable development of DNA synthesis chip technology to commercial scale. Read more ...